ADC Therapeutics SA (ADCT) stock
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.07 (-4.96%)
Close on Nov 13, 2026Market cap $171.08MP/E –Yield –
ADC Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ADC Therapeutics's total debt was $7.80M at Sep 30, 2026. For fiscal 2025 it was $3.00M. The highest annual figure on record is $93.73M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00M | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $12.47M | -86.7% |
| FY2021 | Dec 31, 2021 | $93.73M | +144.0% |
| FY2020 | Dec 31, 2020 | $38.41M | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.80M | – |
| Q2 FY2026 | Jun 30, 2026 | $6.18M | -56.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.64M | -66.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.00M | -75.9% |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $14.33M | -85.1% |
| Q2 FY2023 | Jun 30, 2023 | $13.86M | -85.4% |
| Q4 FY2022 | Dec 31, 2022 | $12.47M | -86.7% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $96.42M | +6.1% |
| Q1 FY2022 | Mar 31, 2022 | $94.96M | +141.2% |
| Q4 FY2021 | Dec 31, 2021 | $93.73M | +144.0% |
| Q3 FY2021 | Sep 30, 2021 | $92.45M | – |
| Q2 FY2021 | Jun 30, 2021 | $90.84M | – |
| Q1 FY2021 | Mar 31, 2021 | $39.37M | – |
| Q4 FY2020 | Dec 31, 2020 | $38.41M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?